Which Inositol Is Best? Myo vs. D-Chiro

For most goals, myo-inositol is the better-supported form and the one to reach for if you’re choosing only one. D-chiro-inositol plays a real but narrower role, mainly helping tissues like muscle and liver handle glucose. The strongest evidence, especially for polycystic ovary syndrome (PCOS), fertility, and metabolic health, favors either myo-inositol alone or a combination of the two at a specific 40:1 ratio that mirrors what your blood naturally contains. That ratio turns out to matter a lot, and getting it wrong can actually backfire.

Two Forms, Two Jobs

Your body makes both myo-inositol (MI) and D-chiro-inositol (DCI) from glucose, and they aren’t interchangeable. MI is a precursor for a signaling molecule that helps relay messages from hormones like insulin, FSH (the hormone that drives egg maturation), and TSH (the hormone that governs thyroid function).¹ DCI, by contrast, works downstream of insulin in tissues that store or burn glucose. It helps activate enzymes involved in glucose disposal, essentially telling muscle and liver cells to process sugar faster.²

Your body converts MI into DCI using an enzyme called an epimerase, and different tissues run this conversion at different rates depending on how much DCI they need. Insulin actually stimulates the conversion, which is why insulin-sensitive tissues like muscle tend to have more DCI relative to MI. This conversion has been directly demonstrated in rat liver, where the enzyme depends on specific coenzymes to function.³ The key takeaway is that your body already makes DCI from MI on demand, so flooding the system with DCI from the outside can throw off the balance in tissues that don’t want extra.

The 40:1 Ratio and Where It Comes From

In healthy human blood, MI and DCI exist in roughly a 40:1 ratio. This number has become central to how researchers and clinicians think about inositol supplementation. The idea is simple: if you’re going to supplement both forms, match what the body already does. A combination at the 40:1 ratio has been shown to reduce insulin resistance, lower androgen levels, cut cardiovascular risk markers, and help restore regular menstrual cycles with spontaneous ovulation in women with PCOS.⁴ Clinical evidence has pointed to this ratio as optimal for restoring ovulation in PCOS specifically.⁵

Interestingly, some researchers have started questioning whether even 40:1 provides too much DCI. A 2024 review noted that while evidence is insufficient to recommend DCI alone, the 40:1 combination is effective, and there is enough rationale to investigate higher ratios like 66:1 or even 100:1 as potentially better options.⁶ The direction of the research, in other words, is leaning toward less DCI rather than more.

The D-Chiro-Inositol Paradox in the Ovary

This is where the story gets genuinely counterintuitive and where people run into trouble by taking DCI alone or in overly generous doses. Unlike muscle and liver, ovaries never become insulin resistant. In women with PCOS who have high insulin levels, the ovaries keep responding to insulin’s signal to convert MI into DCI. The result is that ovaries end up flooded with DCI and depleted of MI, which is the opposite of what they need. MI is essential for FSH signaling, which drives egg maturation. When MI drops too low in the ovary, oocyte quality suffers.⁷

This isn’t just theoretical. A dose-response study gave women with PCOS undergoing fertility treatment either a placebo or escalating doses of DCI (300, 600, 1,200, or 2,400 mg per day). As the DCI dose went up, oocyte quality went down in a clear staircase pattern. The number of immature oocytes climbed, the number of mature eggs dropped, and embryo quality deteriorated significantly.⁸ If you’re trying to conceive, supplementing DCI at high doses without MI could be actively counterproductive.

Myo-Inositol and Female Fertility

The evidence for MI in female reproductive health is substantially stronger than for DCI. A meta-analysis of randomized controlled trials in women with PCOS found that MI supplementation significantly lowered fasting insulin and a key measure of insulin resistance called the HOMA index. There was also a trend toward lower testosterone, and women who took MI for at least 24 weeks showed a meaningful rise in sex hormone-binding globulin, a protein that mops up excess androgens.⁹

In fertility treatment settings, MI has shown direct benefits for egg quality. A double-blind trial in women with PCOS undergoing IVF found that MI supplementation led to more follicles of usable size, more recovered oocytes, better embryo scores, and fewer immature eggs.¹⁰ These are the kinds of outcomes that translate into real differences during an IVF cycle.

When the two forms are combined at the 40:1 ratio, the metabolic and reproductive benefits appear to stack. A study of young overweight women with PCOS found that the combination lowered LH, free testosterone, fasting insulin, and insulin resistance while raising estradiol and sex hormone-binding globulin. No significant side effects were recorded.¹¹ The practical interpretation: MI handles the ovarian side, DCI in a small amount helps at the whole-body insulin level, and together they cover more ground than either alone.

Male Fertility

MI isn’t just for women. A systematic review and meta-analysis examining MI’s effect on sperm quality found a significant increase in both total and progressive sperm motility, higher testosterone levels, and a significant reduction in sperm DNA fragmentation.¹² In a clinical trial of men with poor sperm quality undergoing intrauterine insemination (IUI), MI treatment improved sperm motility and doubled the pregnancy rate compared to controls, from about 9% to 18%.¹³

The research on DCI for male fertility is essentially nonexistent by comparison. When men ask which form to take, MI is the only one with meaningful clinical evidence behind it.

Pregnancy and Gestational Diabetes Prevention

One of the most compelling applications for MI is reducing the risk of gestational diabetes (GDM) in at-risk pregnant women. A meta-analysis of randomized controlled trials found that MI supplementation starting around the 12th to 13th week of pregnancy significantly reduced the risk of developing GDM, cutting it by about 70% compared to placebo.¹⁴ A secondary analysis pooling data from three randomized trials found that MI treatment also reduced the risk of preterm birth and macrosomia (an abnormally large baby at delivery), in addition to cutting GDM diagnoses roughly in half.¹⁵

The populations studied in these trials were women considered high-risk for GDM, including those who were overweight, had PCOS, or had a family history of type 2 diabetes.¹⁶ These results don’t necessarily mean every pregnant woman should supplement MI, but for those with known risk factors, the signal is strong. DCI has not been studied in this context with anywhere near the same rigor.

Thyroid Health and Subclinical Hypothyroidism

MI participates in TSH signaling, so its connection to thyroid function isn’t surprising, but the clinical results are still worth paying attention to. Multiple studies have found that combining MI with selenium significantly lowers TSH in people with subclinical hypothyroidism, whether or not they also have autoimmune thyroiditis (Hashimoto’s).¹⁷ One trial found TSH dropped from about 4.3 to 3.1 after treatment with MI plus selenium in patients with autoimmune thyroiditis.¹⁸ A six-month study confirmed that the combination improved both thyroid hormone levels and markers of autoimmunity.¹⁹

It’s worth noting that it’s always MI studied in this context, not DCI. The selenium component also matters and shouldn’t be overlooked. People with overt hypothyroidism already on levothyroxine shouldn’t assume MI is a substitute, but for the subclinical range, these findings are encouraging.

Metabolic Syndrome Without PCOS

MI’s insulin-sensitizing effects aren’t limited to reproductive-age women with PCOS. A randomized, placebo-controlled study in postmenopausal women with metabolic syndrome found that MI supplementation on top of dietary changes led to a 75% improvement in insulin resistance (measured by HOMA), a 20% drop in triglycerides, a 22% increase in HDL cholesterol, and a meaningful reduction in blood pressure, all significantly better than diet plus placebo.²⁰ That study specifically enrolled postmenopausal women, so the results shouldn’t be assumed to generalize to all populations, but they suggest MI’s metabolic benefits extend well beyond PCOS.

Mental Health Applications

This is one area where enthusiasm has consistently outrun the evidence. MI acts as a precursor for signaling molecules in the brain, which led researchers starting in the 1990s to test high-dose MI (often 12 to 18 grams per day) for depression, anxiety, OCD, and panic disorder. Early small studies were promising. One crossover trial comparing MI at up to 18 grams per day with fluvoxamine (a standard SSRI) for panic disorder found MI reduced panic attacks more than the drug did in the first month, with fewer side effects like nausea and fatigue.²¹

However, when the broader literature is pooled, the picture deflates. A meta-analysis of randomized trials found no statistically significant effect of inositol on depressive symptoms, anxiety symptoms, or OCD symptoms.²² A more recent narrative review echoed this, concluding that while imaging and biomolecular studies point to a role for inositol in mood disorders, clinical trials have mostly failed to show meaningful improvement, with the possible exception of panic disorder specifically.²³ If you’re taking MI for PCOS or metabolic reasons and happen to notice reduced anxiety, that’s a plausible bonus. But supplementing MI solely as a psychiatric treatment, outside of panic disorder, is not well-supported.

Tolerability and How It Compares to Metformin

One of MI’s practical advantages is that it’s very well tolerated. The most common complaint at standard doses (2 to 4 grams per day) is mild gastrointestinal upset, usually at higher doses. Compared to metformin, which is the standard pharmaceutical intervention for insulin resistance in PCOS, inositol therapy often shows similar effectiveness on selected outcomes with better tolerability and fewer GI side effects.²⁴ That doesn’t mean MI replaces metformin for everyone, but for people who struggle with metformin’s side effects or prefer a supplement-based approach, it’s a reasonable option to discuss with a doctor.

One safety note that doesn’t get enough attention involves premature infants. An early trial from the 1990s found that MI supplementation reduced respiratory complications and retinopathy in preemies.²⁵ But a much larger, more recent randomized trial in infants younger than 28 weeks found that MI did not reduce retinopathy and was associated with higher rates of death compared to placebo. The trial was stopped early because of these safety signals.²⁶ This is a reminder that “natural” does not mean “universally safe,” and context matters enormously.

Absorption Quirks Worth Knowing

If you’re taking a supplement that combines MI and DCI in the same capsule, there’s a pharmacokinetic wrinkle to be aware of. A study measuring blood levels after oral dosing found that taking MI together with DCI reduced MI’s peak blood concentration by about 23% and its overall absorption by roughly 19% compared to taking MI alone. Certain sugars and glucose-transporter inhibitors in the formulation worsened the effect further.²⁷ DCI itself has relatively low absorption, likely relying on passive diffusion rather than active transport, though certain protein fragments from alpha-lactalbumin (a whey protein) appear to enhance its uptake significantly.²⁸

What this means practically: if you’re taking a combination product, the MI you’re absorbing may be somewhat less than what the label suggests. Some supplement makers now separate the two forms or add alpha-lactalbumin to improve DCI uptake. Whether the absorption reduction is clinically meaningful at typical doses is still debated, but it’s something to keep in mind if you feel a combination isn’t working as well as MI alone did.

Supplement Quality Is a Real Problem

Here’s something that rarely comes up in discussions about myo vs. D-chiro: the DCI in your supplement may not actually be there. A laboratory analysis of four commercially available inositol supplements found that while MI content closely matched label claims (within about 5 to 8%), DCI accuracy was all over the map. Two products were reasonably close to their labels, but one contained no detectable DCI at all, and another had roughly half of its claimed amount.²⁹

DCI is harder and more expensive to produce than MI, which creates an obvious incentive for corner-cutting. If you’re paying a premium for a 40:1 combo product and the DCI component is missing or underdosed, you’re essentially taking MI alone at a higher price. MI-only products, which are cheaper and more reliably dosed, may be the more practical choice unless you can verify the quality of the DCI component through third-party testing.

Food Sources and What Your Body Already Makes

Most people get some MI from food. The richest dietary sources are fruits, beans, grains, and nuts.³⁰ A typical Western diet provides roughly a gram per day, and your kidneys synthesize additional MI from glucose. DCI is present in foods in much smaller amounts, consistent with its lower physiological concentration. For most healthy people eating a varied diet, the body’s own production and dietary intake of both forms are sufficient. Supplementation becomes relevant when there’s a specific metabolic disruption, like the insulin resistance and hormonal imbalance seen in PCOS, or when higher doses are being studied for conditions like gestational diabetes prevention.

People sometimes ask whether they can get therapeutic doses from diet alone. The short answer is no. Clinical trials typically use 2 to 4 grams of MI per day, which is several times what you’d get even from an inositol-rich diet. You’d need to eat unrealistic quantities of cantaloupe or citrus to hit those numbers.

When DCI Alone Might Make Sense

Given everything above, is there any situation where DCI alone is the right choice? The honest answer is: rarely, and the evidence is thin. The original rationale for DCI supplementation came from observations that people with type 2 diabetes had lower DCI levels in their urine and tissues, suggesting a deficiency. Some small studies found that DCI supplements improved insulin sensitivity in women with PCOS. But the research has not kept pace with the marketing. The most recent reviews note that evidence for DCI alone is “insufficient or controversial,” and the trend in the literature is toward MI alone or the combination rather than standalone DCI.⁶

If someone is primarily concerned with systemic insulin resistance and has no interest in fertility or ovarian health, DCI might seem appealing in theory. But even then, MI improves insulin resistance on its own, and combining it with a small amount of DCI covers the metabolic angle without the risks. There’s simply no well-supported scenario where DCI alone outperforms MI or the combination.